Thus, the endogenous tumor-reactive T cell effector function was increased, with more IFN-γ/TNF-α-positive CAR-negative T cells present in both the tumor and the spleen as compared to mice treated with CAR-T cells without CD40L [102]. The gene discussed is CD40LG; the disease is neoplasm.